Try our beta test site

Safety and Immunogenicity Study of Adenovirus-vectored, Intranasal Pandemic Influenza Vaccine.

This study has been completed.
Information provided by (Responsible Party):
Altimmune, Inc. Identifier:
First received: September 17, 2008
Last updated: December 31, 2015
Last verified: September 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2011
  Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)